MarketWise (MKTW) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Mar, 2026Executive summary
Q4 2025 net revenue was $83.4M and net income reached $14.0M, with billings up 42% year-over-year and 24% sequentially from Q3 2025.
FY 2025 billings were $271.2M, up 13.4% from FY 2024, while net revenue declined 19.7% to $328.1M due to deferred revenue recognition.
FY 2025 net income was $64.0M, down from $93.1M in FY 2024, but cash from operating activities (CFFO) improved to $46.0M from $(22.2)M.
Board increased regular dividend by 25% and resumed a $50M share buyback program.
FY 2026 guidance raised: billings target $300M (+10% YoY), CFFO target $50M (+9% YoY), and dividend target $1.80 per Class A share.
Financial highlights
Q4 2025 billings were $78.9M, up 42% YoY; CFFO for Q4 was $24.2M, up $18.2M YoY.
FY 2025 CFFO was $46.0M, exceeding original guidance by 53%.
Cash and cash equivalents at year-end 2025 were $70.1M, with no debt outstanding.
Paid subscribers declined to 374K at year-end 2025 from 506K in 2024, but ARPU increased to $670.
Operating expenses decreased across all major categories, supporting margin expansion.
Outlook and guidance
FY 2026 billings guidance raised to $300M (+10% YoY) and CFFO to $50M (+9% YoY).
Dividend guidance for FY 2026 is $1.80 per Class A share, reflecting a 13% yield at current prices.
Tax distributions expected to decline by $15M in FY 2026, with cash balances projected to dip in H1 and recover in H2.
Latest events from MarketWise
- Q4 2024 saw a return to billings growth, improved margins, and renewed strategic focus.MKTW
Emerging Growth Conference 7810 Jan 2026 - Shareholders to vote on director elections, equity plan amendment, and new auditor ratification.MKTW
Proxy Filing1 Dec 2025 - Vote on reverse stock split and share reduction to maintain Nasdaq listing and streamline capital structure.MKTW
Proxy Filing1 Dec 2025 - Vote to approve a 1-for-20 reverse stock split and reduce authorized shares for Nasdaq compliance.MKTW
Proxy Filing1 Dec 2025 - Key votes include director elections, incentive plan amendment, and auditor ratification.MKTW
Proxy Filing1 Dec 2025 - Q3 2025 net income was $17.9M on $81.3M revenue, with ARPU up 35.5% and a buyout proposal pending.MKTW
Q3 20256 Nov 2025 - Q2 2025 saw revenue and subscribers fall, but cash flow, billings, and capital returns strengthened.MKTW
Q2 20257 Aug 2025 - Net income rose to $22.7M in Q3 2024 despite sharp declines in revenue and subscribers.MKTW
Q3 202413 Jun 2025 - Net income surged to $21.2M in Q2 2024, while billings fell 40% amid Legacy Research wind-down.MKTW
Q2 202413 Jun 2025